Moreover, despite the encouraging preclinical data, rigorous phase III trials are necessary to confirm the safety, tolerability, and specificity of GLP-1RAs in pain management
Accurate comprehension of the WADA Prohibited List structure and scope is critical for athletes and supplement manufacturers to avoid inadvertent anti-doping rule violations and safeguard athletic eligibility and brand reputation
Exp Ther Med 23:363 Ferrario M, Cambiaghi A, Brunelli L, Giordano S, Caironi P, Guatteri L, Raimondi F, Gattinoni L, Latini R, Masson S, Ristagno G, Pastorelli R (2016) Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach
Interestingly, observational data from 200 WeightWatchers members showed that those who stopped GLP-1 medications while following a structured healthy habits program not only maintained their weight loss but even lost an additional 1.8% of their body weight over 13 weeks
Energy levels may fluctuate initially